Allergy Diagnostics Market Growth Outlook From $7.94 Billion In 2026 To $13.03 Billion By 2030
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Allergy Diagnostics Market Size, Value And Growth Trajectory Through 2030
The allergy diagnostics market size has undergone rapid expansion in recent years. It is anticipated to expand from $6.99 billion in 2025 to $7.94 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.5%. This historical growth can be attributed to the rising global incidence of allergies, the widespread adoption of skin prick and intradermal tests, the establishment of more hospital-based laboratories, increasing understanding of allergy management, and the constrained supply of advanced in-vitro kits.
The allergy diagnostics market size is anticipated to experience significant growth over the coming years, with projections indicating it will reach $13.03 billion by 2030, expanding at a compound annual growth rate (CAGR) of 13.2%. This forecasted growth is driven by advancements in component-resolved diagnostics, the integration of automation into allergy testing, increased investment in research on novel allergens, the expansion of academic and diagnostic laboratories, and a rising demand for personalized allergy treatments. Major trends during this period include a heightened demand for accurate allergy diagnostics, the increasing adoption of in-vitro testing methods, the broadening scope of food and drug allergen testing, a greater use of ELISA, RAST, and CRD kits, and a focus on rapid and point-of-care allergy detection.
Get A Free Sample Report With In-Depth Market Insights:
Allergy Diagnostics Market Development Factors: What’s Supporting Demand?
The expanding incidence of allergic conditions is set to drive the expansion of the allergy diagnostics market. This escalation in allergic ailments is linked to heightened environmental contamination stemming from vehicular emissions and various industrial activities. An allergic reaction refers to an irregular response by the immune system when exposed to an allergen. Examples of allergic diseases encompass anaphylaxis, allergic rhinitis (commonly known as ‘hay fever’), food allergies, dermal allergies, and allergic asthma. The primary and most crucial treatment for allergic conditions involves the avoidance of the specific allergen. Consequently, accurate allergy diagnosis plays a vital role in enabling successful allergy management. As an illustration, data from September 2024, provided by Anaphylaxis UK, a UK-based charity, indicates that 20% of food allergy incidents happen within school environments. Furthermore, one in five children affected by food allergies endure bullying, and one in five parents report experiencing anxiety ranging from moderate to extreme. Almost all parents of children with allergies display symptoms of post-traumatic stress (PTSS), with these rates being seven times greater among parents whose children rely on adrenaline auto-injectors (AAIs). Therefore, the escalating prevalence of allergic illnesses will continue to bolster the expansion of the allergic diagnostics market.
Allergy Diagnostics Market Segmentation: How Does The Market Break Down By Category?
The allergy diagnostics market covered in this report is segmented –
1) By Test Type: In-Vivo Allergy Tests, In-Vitro Allergy Tests
2) By Allergen: Inhaled Allergens, Food Allergens, Drug Allergens
3) By Products: Consumables, Instruments
4) By End User: Diagnostics Laboratories, Hospital-based Laboratories, Academic and Research Institutes
Subsegments:
1) By In-Vivo Allergy Tests: Skin Prick Tests, Intradermal Tests, Patch Tests, Oral Food Challenge Tests
2) By In-Vitro Allergy Tests: Enzyme-Linked Immunosorbent Assay (ELISA), Radioallergosorbent Test (RAST), Component-Resolved Diagnostics (CRD), Basophil Activation Tests (BAT)
Allergy Diagnostics Market Transformation Trends: What Innovations Are Driving Change?
Major companies operating in the allergy diagnostics market are introducing new technologies, such as an AI-driven allergy component testing platform, to boost their profitability within the market. An AI-powered allergy component testing platform is a technologically advanced system that utilizes artificial intelligence (AI) to analyze and interpret the results of allergy tests. For instance, in May 2023, Metropolis, an India-based pathology lab and diagnostic center, launched an artificial intelligence (AI)-powered platform for testing allergy components that can identify 127 respiratory allergens, 10 contact allergens, and 158 food allergens. This testing platform offers extensive knowledge for identifying and optimizing an individual’s allergy treatment course and aids clinicians in making informed clinical decisions by employing component-resolved diagnostics (CRD) and artificial intelligence (AI).
Allergy Diagnostics Market Competitive Overview And Top Companies
Major companies operating in the allergy diagnostics market are bioMérieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Stallergenes Greer, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Eurofins Viracor Inc., VRL Laboratories
View The Full Allergy Diagnostics Market Report:
Allergy Diagnostics Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the allergy diagnostics market in 2025. The regions covered in the allergy diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
